论文部分内容阅读
我院门诊患者口服卡托普利曾发现致支气管哮喘1例。现报告如下: 1 病例介绍 患者,男,59岁,因眩晕、头痛、失眠,于1998年2月17日来我院门诊。体检:体温37.2℃,心率81次/min,血压28.7kPa/19.2kPa,双肺呼吸无异常,肝脾未扪及,血常规正常。诊断:原发性高血压病。给予卡托普利片(石家庄市龙华药业股份有限公司,批号970601)25mg,tid,po。用药第5天,出现鼻痒、喷嚏、咳嗽、气促等症状,来院复诊。体检:血压21.7kPa/14.3kPa,心率80次/min,双肺布满哮鸣音,X线检查未见异常。确诊为支气管哮喘。嘱其停服卡托
Outpatient patients in our hospital oral captopril had been found in 1 case of bronchial asthma. Now report as follows: 1 case description The patient, male, 59 years old, due to dizziness, headache, insomnia, in February 17, 1998 came to our hospital. Physical examination: body temperature 37.2 ℃, heart rate 81 beats / min, blood pressure 28.7kPa / 19.2kPa, no abnormal lungs breathing, liver and spleen not palpable, blood normal. Diagnosis: Primary Hypertension. Give captopril tablets (Shijiazhuang Longhua Pharmaceutical Co., Ltd., lot number 970601) 25mg, tid, po. The first 5 days of treatment, itchy nasal itching, sneezing, cough, shortness of breath and other symptoms, to the hospital referral. Physical examination: blood pressure 21.7kPa / 14.3kPa, heart rate 80 beats / min, lungs covered with wheeze, X-ray examination showed no abnormalities. Diagnosed as bronchial asthma. Instruct Cato to stop serving it